SCHEMBL8548965

SCHEMBL8548965

CCCN1c2nc(OS(=O)(=O)C(F)(F)F)ccc2NC(=O)c2cccnc21

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 3/20 0.36
LMNA P02545 2/20 0.36
CHRM2 P08172 2/20 0.36
USP2 O75604 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM5 P08912 1/20 0.36
CYP2D6 P10635 1/20 0.36
CHRM3 P20309 1/20 0.36
GMNN O75496 1/20 0.35
APEX1 P27695 1/20 0.35
RAB9A P51151 1/20 0.34
DRD2 P14416 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8551857 0.84 CYP3A4 (0.37) CYP1A2DRD2DRD4DRD3
SCHEMBL8301869 0.78 CHRM2 (0.48) CHRM1LMNACHRM2USP2ALDH1A1
SCHEMBL8550821 0.77 CYP3A4 (0.42) ALDH1A1CYP1A2
SCHEMBL8706553 0.73 AKT1 (0.38) CHRM1LMNACHRM2USP2ALDH1A1
SCHEMBL8300334 0.68 RAB9A (0.50) CHRM1LMNACHRM2USP2ALDH1A1
SCHEMBL8548089 0.68 ALDH1A1 (0.41) CHRM1LMNAALDH1A1DRD2DRD4
SCHEMBL8417093 0.67 BRD4 (0.33) LMNAALDH1A1DRD2DRD4DRD3
SCHEMBL8790717 0.63 RAB9A (0.53) CHRM1LMNACHRM2USP2ALDH1A1
SCHEMBL8300867 0.63 RAB9A (0.53) CHRM1LMNACHRM2USP2ALDH1A1
SCHEMBL169540 0.63 PDE4A (0.48) LMNAALDH1A1CYP2D6GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5837704-A PREVENTION OR TREATMENT OF AIDS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 1998-11-17 US disclosed
EP-0745083-B1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION BOEHRINGER INGELHEIM PHARMA (US) 1998-05-20 EP disclosed